Latest News

The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.

Yale researchers, led by Professor Mark Saltzman, have successfully created an mRNA no-shot COVID vaccine, which successfully protects against COVID-19 in mice.

Using microparticles instead of injection as a delivery system, Yale scientists have developed an inhalable vaccine that protects against the SARS-CoV-2 virus. The technique also has the potential to deliver gene replacement therapy and other treatments to the lungs.

Cancer vaccines utilizing mRNA vaccine technology have such potential that ARPA-H, a newly established White House-originated program, has made it the focus of its first ever grant to be split among teams at Emory University, Yale School of Medicine, and the University of Georgia.

The new model will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases.

A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.

A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.

When activated, a protein found in cells that line the body’s tissues can inhibit viral spread — offering the potential for a new defense against COVID-19.